These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29075792)

  • 1. Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.
    Rousseau A; Van Dreden P; Khaterchi A; Larsen AK; Elalamy I; Gerotziafas GT
    Int J Oncol; 2017 Dec; 51(6):1793-1800. PubMed ID: 29075792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.
    Rousseau A; Larsen AK; Van Dreden P; Sabbah M; Elalamy I; Gerotziafas GT
    Int J Oncol; 2017 Dec; 51(6):1747-1756. PubMed ID: 29075790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells.
    AmraneDjedidi R; Rousseau A; Larsen AK; Elalamy I; Van Dreden P; Gerotziafas GT
    Thromb Res; 2020 Mar; 187():170-179. PubMed ID: 32006891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
    Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
    Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
    Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
    Zhao L; Bi Y; Kou J; Shi J; Piao D
    J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents.
    Tran HCM; Mbemba E; Mourot N; Faltas B; Rousseau A; Lefkou E; Sabbah M; van Dreden P; Gerotziafas G
    Thromb Res; 2024 Jun; 238():172-183. PubMed ID: 38723522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor.
    Sidibe F; Spanoudaki A; Vanneaux V; Mbemba E; Larghero J; Van Dreden P; Lotz JP; Elalamy I; Larsen AK; Gerotziafas GT
    Clin Appl Thromb Hemost; 2018 May; 24(4):684-690. PubMed ID: 28681632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
    Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA.
    Lysov Z; Dwivedi DJ; Gould TJ; Liaw PC
    Blood Coagul Fibrinolysis; 2017 Jan; 28(1):72-82. PubMed ID: 26919453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinoma.
    Papageorgiou C; Vandreden P; Marret E; Bonnet F; Robert F; Spyropoulos A; Galea V; Elalamy I; Hatmi M; Gerotziafas GT
    Thromb Res; 2013 Nov; 132(5):584-91. PubMed ID: 24094602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients.
    Yang C; Ma R; Jiang T; Cao M; Zhao L; Bi Y; Kou J; Shi J; Zou X
    Tumour Biol; 2016 Jun; 37(6):7881-91. PubMed ID: 26700666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia.
    Mooberry MJ; Bradford R; Hobl EL; Lin FC; Jilma B; Key NS
    J Thromb Haemost; 2016 May; 14(5):1031-42. PubMed ID: 26857798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa.
    Gerotziafas GT; Rousseau A; van Dreden P; Mbemba E; Gkalea V; Khaterchi A; Larsen A; Elalamy I
    Thromb Res; 2016 Apr; 140 Suppl 1():S169. PubMed ID: 27161675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory characterization of leukemic cell procoagulants.
    Hudák R; Debreceni IB; Deák I; Szabó GG; Hevessy Z; Antal-Szalmás P; Osterud B; Kappelmayer J
    Clin Chem Lab Med; 2017 Jul; 55(8):1215-1223. PubMed ID: 28593927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles.
    Lima LG; Oliveira AS; Campos LC; Bonamino M; Chammas R; Werneck C; Vicente CP; Barcinski MA; Petersen LC; Monteiro RQ
    Thromb Haemost; 2011 Oct; 106(4):712-23. PubMed ID: 21800005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
    Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity.
    Collier ME; Mah PM; Xiao Y; Maraveyas A; Ettelaie C
    Thromb Haemost; 2013 Nov; 110(5):966-76. PubMed ID: 23945646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
    Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
    Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.